Free Trial

uniQure (QURE) Competitors

uniQure logo
$61.59 +2.26 (+3.81%)
As of 01:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

QURE vs. RDY, VTRS, ROIV, QGEN, ELAN, BBIO, MRNA, RVMD, VRNA, and RYTM

Should you be buying uniQure stock or one of its competitors? The main competitors of uniQure include Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), Qiagen (QGEN), Elanco Animal Health (ELAN), BridgeBio Pharma (BBIO), Moderna (MRNA), Revolution Medicines (RVMD), Verona Pharma PLC American Depositary Share (VRNA), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "pharmaceutical products" industry.

uniQure vs. Its Competitors

uniQure (NASDAQ:QURE) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

uniQure currently has a consensus target price of $71.75, suggesting a potential upside of 16.84%. Dr. Reddy's Laboratories has a consensus target price of $16.95, suggesting a potential upside of 15.66%. Given uniQure's higher probable upside, analysts plainly believe uniQure is more favorable than Dr. Reddy's Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
uniQure
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.83
Dr. Reddy's Laboratories
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83

Dr. Reddy's Laboratories has a net margin of 16.99% compared to uniQure's net margin of -1,387.98%. Dr. Reddy's Laboratories' return on equity of 17.25% beat uniQure's return on equity.

Company Net Margins Return on Equity Return on Assets
uniQure-1,387.98% -1,010.74% -33.27%
Dr. Reddy's Laboratories 16.99%17.25%11.63%

In the previous week, Dr. Reddy's Laboratories had 3 more articles in the media than uniQure. MarketBeat recorded 3 mentions for Dr. Reddy's Laboratories and 0 mentions for uniQure. Dr. Reddy's Laboratories' average media sentiment score of 1.79 beat uniQure's score of 0.00 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the news media.

Company Overall Sentiment
uniQure Neutral
Dr. Reddy's Laboratories Very Positive

78.8% of uniQure shares are owned by institutional investors. Comparatively, 3.8% of Dr. Reddy's Laboratories shares are owned by institutional investors. 4.8% of uniQure shares are owned by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Dr. Reddy's Laboratories has higher revenue and earnings than uniQure. uniQure is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
uniQure$27.12M124.25-$239.56M-$3.92-15.67
Dr. Reddy's Laboratories$334.26B0.04$663M$0.6622.20

uniQure has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.

Summary

Dr. Reddy's Laboratories beats uniQure on 9 of the 15 factors compared between the two stocks.

Get uniQure News Delivered to You Automatically

Sign up to receive the latest news and ratings for QURE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QURE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QURE vs. The Competition

MetricuniQureMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.37B$3.42B$6.19B$10.78B
Dividend YieldN/A2.26%5.72%4.83%
P/E Ratio-15.6823.5529.8828.59
Price / Sales124.25270.54503.00189.86
Price / CashN/A44.5736.5560.64
Price / Book-438.6410.4212.026.62
Net Income-$239.56M-$52.53M$3.32B$276.83M
7 Day Performance5.88%2.08%1.63%2.10%
1 Month Performance29.28%10.95%6.26%2.69%
1 Year Performance847.69%13.94%61.43%34.06%

uniQure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QURE
uniQure
2.297 of 5 stars
$61.59
+3.8%
$71.75
+16.5%
+822.0%$3.39B$27.12M-15.74500Analyst Forecast
Gap Up
RDY
Dr. Reddy's Laboratories
2.9315 of 5 stars
$14.44
+1.5%
$16.95
+17.4%
-6.5%$12.05B$3.81B21.8727,811News Coverage
Earnings Report
VTRS
Viatris
3.1715 of 5 stars
$10.17
+0.7%
$11.17
+9.8%
-10.7%$11.86B$14.74B-3.5132,000Analyst Forecast
ROIV
Roivant Sciences
2.6639 of 5 stars
$17.26
+0.9%
$19.94
+15.5%
+55.9%$11.79B$29.05M-24.66860
QGEN
Qiagen
4.1331 of 5 stars
$48.29
+0.3%
$49.69
+2.9%
+20.6%$10.73B$1.98B28.535,765Positive News
ELAN
Elanco Animal Health
2.7522 of 5 stars
$21.42
+4.4%
$19.14
-10.6%
+74.0%$10.64B$4.44B24.919,000
BBIO
BridgeBio Pharma
4.5052 of 5 stars
$54.92
-0.2%
$65.06
+18.5%
+120.1%$10.50B$221.90M-13.43400Analyst Forecast
MRNA
Moderna
4.2527 of 5 stars
$26.01
-4.2%
$39.93
+53.5%
-50.8%$10.16B$3.24B-3.455,800Trending News
Analyst Forecast
RVMD
Revolution Medicines
4.3137 of 5 stars
$54.10
+8.9%
$76.67
+41.7%
+10.2%$10.11B$11.58M-12.02250Analyst Forecast
High Trading Volume
VRNA
Verona Pharma PLC American Depositary Share
1.0712 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RYTM
Rhythm Pharmaceuticals
2.8678 of 5 stars
$110.28
-0.8%
$107.21
-2.8%
+122.6%$7.32B$130.13M-36.64140

Related Companies and Tools


This page (NASDAQ:QURE) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners